Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jacc.2009.07.010 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Treatment Initiation Patterns, Modifications, and Medication Adherence Among Newly Diagnosed Heart Failure Patients: A Retrospective Claims Database Analysis.
J Manag Care Spec Pharm
May 2016
4 Novartis Pharmaceuticals, East Hanover, New Jersey, United States.
Background: Heart failure (HF) is a debilitating disease associated with high mortality and frequent hospitalizations. American College of Cardiology Foundation and American Heart Association (ACCF/AHA) guidelines recommend the following drug classes for HF treatment: angiotensin-converting enzyme inhibitor (ACEI), angiotensin receptor II blocker (ARB) for patients intolerant to ACEI, beta blocker (BB), and aldosterone antagonist (AA).
Objective: To examine, in a real-word setting, the treatment initiation pattern among newly diagnosed HF patients in the United States, subsequent treatment modifications, hospitalizations and the impact of hospitalizations on therapy changes, and treatment adherence and persistence.
An update on the management of implanted cardiac devices during electrosurgical procedures.
Gastrointest Endosc
December 2013
Gastroenterology, Eastern Virginia Medical School, Norfolk, Virginia, USA.
To date, the major guidelines for the management of implanted cardiac devices during electrosurgical procedures have come from 1 of several major medical societies.These most recent guidelines are from the ACCF/AHA in 2009, a combined consensus statement from the Heart Rhythm Society and the American Society of Anesthesiologists in 2011, as well as an update from the ASGE in 2007. Tables 1 and 2 summarize the most recent recommendations by society.
View Article and Find Full Text PDFQuality of care for heart failure patients hospitalized for any cause.
J Am Coll Cardiol
January 2014
Department of Medicine, NYU School of Medicine, New York, New York.
Objectives: The study sought to assess the quality of care for heart failure patients who are hospitalized for all causes.
Background: Performance measures for heart failure target patients with a principal diagnosis of heart failure. However, patients with heart failure are commonly hospitalized for other causes and may benefit from treatments such as angiotensin-converting enzyme (ACE) inhibitors for left ventricular (LV) systolic dysfunction.
Prognostic implications of percutaneous coronary interventions performed according to the appropriate use criteria for coronary revascularization.
Cardiovasc Revasc Med
August 2014
Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, USA.
Objectives: To assess the prognostic implication of the ACCF/AHA/SCAI appropriate use criteria (AUC) for coronary revascularization in a cohort of non-acute coronary syndrome patients.
Background: The AUC for coronary revascularization were developed in order to deliver high-quality care; however, the prognostic impact of these criteria remains undefined.
Methods: Consecutive patients (n=3817) undergoing elective percutaneous coronary intervention (PCI) at MedStar Washington Hospital Center since the 2009 AUC publication were retrospectively grouped according to AUC as an "Appropriate," "Inappropriate," or "Undetermined" indication for PCI.
Recommendations for the treatment of hypertension in the elderly and very elderly--a scotoma within international guidelines.
Swiss Med Wkly
August 2012
Chris Barnard Division of Cardiothoracic Surgerry, University of Cape Town, Groote Schuur Hospital, Cape Town, South Africa.
The recommendations of international scientific societies for the treatment of hypertension in the geriatric population are different. Lack of outcome trials, non-standardised terminology as well as differing levels of evidence contribute to the inconsistencies in the guidelines. This review article compares six international guidelines (ESH-ESC 2007/2009, SHG 2009, DHL 2008, CHEP 2010, NICE 2011 and JNC7 2003) as well as the consensus document of the ACCF/AHA 2011 in terms of their recommendations of drug classes, target blood pressure values and the use of combination therapy.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!